EMA Panel Recommends Approval of Erectile Dysfunction Drug

EMA Panel Recommends Acceptance of Erectile Dysfunction Drug
The European Medicines Company's Committee for Medicinal Goods for Human Use (CHMP) has recommended granting advertising and marketing authorization for Spedra (Vivus BV) for the treatment of erectile dysfunction in males. The energetic ingredient in Spedra is the …
Read through far more on Medscape